Organon & Co. Revenues in USD from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Organon & Co. quarterly/annual Revenues history and growth rate from 2019 to Q3 2025.
  • Organon & Co. Revenues for the quarter ending September 30, 2025 was $1.6B, a 1.26% increase year-over-year.
  • Organon & Co. Revenues for the twelve months ending September 30, 2025 was $6.3B, a 1.69% decline year-over-year.
  • Organon & Co. annual Revenues for 2024 was $6.4B, a 2.24% increase from 2023.
  • Organon & Co. annual Revenues for 2023 was $6.26B, a 1.44% increase from 2022.
  • Organon & Co. annual Revenues for 2022 was $6.17B, a 2.06% decline from 2021.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)

Organon & Co. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $6.3B $1.6B +$20M +1.26% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $6.28B $1.59B -$13M -0.81% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $6.29B $1.51B -$109M -6.72% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-02
Q4 2024 $6.4B $1.59B -$6M -0.38% Oct 1, 2024 Dec 31, 2024 10-K/A 2025-11-10
Q3 2024 $6.41B $1.58B +$63M +4.15% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 $6.35B $1.61B -$1M -0.06% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 $6.35B $1.62B +$84M +5.46% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-02
Q4 2023 $6.26B $1.6B +$113M +7.61% Oct 1, 2023 Dec 31, 2023 10-K/A 2025-11-10
Q3 2023 $6.15B $1.52B -$18M -1.17% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-01
Q2 2023 $6.17B $1.61B +$23M +1.45% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $6.15B $1.54B -$29M -1.85% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $6.17B $1.49B -$118M -7.36% Oct 1, 2022 Dec 31, 2022 10-K/A 2025-11-10
Q3 2022 $6.29B $1.54B -$63M -3.94% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $6.36B $1.59B -$10M -0.63% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $6.37B $1.57B +$61M +4.05% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $6.3B $1.6B -$10M -0.62% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $6.31B $1.6B -$13M -0.81% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $6.33B $1.6B +$69M +4.52% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $6.26B $1.51B -$274M -15.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $6.53B $1.61B Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $1.61B Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $1.53B Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $1.78B Jan 1, 2020 Mar 31, 2020 10-Q 2021-06-21

Organon & Co. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $6.4B +$140M +2.24% Jan 1, 2024 Dec 31, 2024 10-K/A 2025-11-10
2023 $6.26B +$89M +1.44% Jan 1, 2023 Dec 31, 2023 10-K/A 2025-11-10
2022 $6.17B -$130M -2.06% Jan 1, 2022 Dec 31, 2022 10-K/A 2025-11-10
2021 $6.3B -$228M -3.49% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $6.53B -$1.25B -16% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $7.78B Jan 1, 2019 Dec 31, 2019 10-K 2022-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.